4.47
price up icon3.95%   0.17
after-market 시간 외 거래: 4.55 0.08 +1.79%
loading

Larimar Therapeutics Inc (LRMR) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
78.11%
49.50
27.79 31.19 31.29 18.26
Operating Income/Loss
78.11%
-49.50
-27.79 -31.19 -31.29 -18.26
Nonoperating Income/Loss
10.99%
1.787
1.61 1.907 2.469 2.765
Income/Loss From Continuing Operations Before Tax
82.23%
-47.71
-26.18 -29.28 -28.82 -15.50
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
82.23%
-47.71
-26.18 -29.28 -28.82 -15.50
Net Income/Loss
82.23%
-47.71
-26.18 -29.28 -28.82 -15.50
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
22.33%
78.32
64.03 63.96 0.8564 63.81
Diluted Average Shares
22.33%
78.32
64.03 63.96 0.8564 63.81
Basic Earnings Per Share
48.78%
-0.61
-0.41 -0.46 -0.46 -0.24
Diluted Earnings Per Share
48.78%
-0.61
-0.41 -0.46 -0.46 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):